Thyrocare Technologies Ltd (THYROCARE) Price & Analysis

Compare

1 Followers

THYROCARE Stock Chart & Stats

₹459.10

-₹16.20(-1.70%)

At close: Jan 08 4:00 PM EST

₹459.10

-₹16.20(-1.70%)

Day’s Range― - ―

52-Week Range₹219.33 - ₹537.97

Previous CloseN/A

Volume114.81K

Average Volume (3M)56.30K

Market Cap

₹66.54B

Enterprise Value₹20.73B

Total Cash (Recent Filing)₹1.55B

Total Debt (Recent Filing)₹0.00

Price to Earnings (P/E)48.3

Beta0.44

Next Earnings

May 21, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield0.68%

Share Statistics

EPS (TTM)4.30

Shares Outstanding159,161,700

10 Day Avg. Volume44,587

30 Day Avg. Volume56,302

Financial Highlights & Ratios

PEG Ratio0.49

Price to Book (P/B)2.35

Price to Sales (P/S)1.87

P/FCF Ratio8.78

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue GrowthConsistent revenue growth indicates robust market positioning and expanding service adoption, supporting long-term business sustainability.

Cash Flow ManagementEffective cash flow management ensures operational efficiency and provides the company with the flexibility to make strategic investments.

Balance Sheet HealthA strong balance sheet with low debt levels minimizes financial risk and provides a stable foundation for future growth opportunities.

Bears Say

Net Profit Margin DeclineA declining net profit margin may indicate rising costs or inefficiencies, which could impact profitability if not addressed.

Capital Expenditure ImpactHigh capital expenditures could strain liquidity, potentially limiting the company's ability to invest in growth or respond to market changes.

Operational Cost OptimizationInefficiencies in cost management could erode margins and reduce competitiveness if not strategically addressed.

Thyrocare Technologies Ltd News

Thyrocare Wins Dual Honours at National Diagnostics Forum 2026

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has provided an announcement. Thyrocare Technologies Limited announced that it has received...

1M ago

Thyrocare Schedules January 28 Earnings Call to Discuss Q3 FY26 Results

The latest update is out from Thyrocare Technologies Ltd ( ($IN:THYROCARE) ). Thyrocare Technologies Limited has scheduled an...

1M ago

Thyrocare Auditor Converts to LLP Without Change in Audit Mandate

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) just unveiled an update. Thyrocare Technologies has announced that its statutory auditor,...

1M ago

Thyrocare Appoints Industry Veteran Rajdeep Panwar as Chief Commercial Officer

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has issued an update. Thyrocare Technologies Limited has appointed senior healthcare and...

2M ago

Thyrocare Names Industry Veteran Rajdeep Panwar as Chief Commercial Officer

The latest announcement is out from Thyrocare Technologies Ltd ( ($IN:THYROCARE) ). Thyrocare Technologies Limited has appointed senior...

2M ago

Thyrocare Technologies Boosts Shareholder Value with Bonus Share Allotment

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has shared an update. Thyrocare Technologies Limited has announced the allotment of...

3M ago

Thyrocare Technologies Approves Key Resolutions to Boost Growth

The latest announcement is out from Thyrocare Technologies Ltd ( ($IN:THYROCARE) ). Thyrocare Technologies Ltd announced the successful...

3M ago

Thyrocare Announces 2:1 Bonus Share Issue

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has issued an update. Thyrocare Technologies Ltd has announced a bonus issue...

3M ago

Thyrocare Technologies Enhances Capital Structure with Key Amendments

Thyrocare Technologies Ltd ( ($IN:THYROCARE) ) has shared an update. Thyrocare Technologies Ltd has announced amendments to its...

3M ago

Thyrocare Technologies Announces Postal Ballot Notice Publication

The latest update is out from Thyrocare Technologies Ltd ( ($IN:THYROCARE) ). Thyrocare Technologies Limited has announced the...

4M ago

THYROCARE FAQ

What was Thyrocare Technologies Ltd’s price range in the past 12 months?

Thyrocare Technologies Ltd lowest stock price was ₹219.33 and its highest was ₹537.97 in the past 12 months.

What is Thyrocare Technologies Ltd’s market cap?

Thyrocare Technologies Ltd’s market cap is ₹66.54B.

When is Thyrocare Technologies Ltd’s upcoming earnings report date?

Thyrocare Technologies Ltd’s upcoming earnings report date is May 21, 2026 which is in 88 days.

How were Thyrocare Technologies Ltd’s earnings last quarter?

Thyrocare Technologies Ltd released its earnings results on Jan 28, 2026. The company reported ₹4.3 earnings per share for the quarter, missing the consensus estimate of ₹4.5 by -₹0.2.

Is Thyrocare Technologies Ltd overvalued?

According to Wall Street analysts Thyrocare Technologies Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Thyrocare Technologies Ltd pay dividends?

Thyrocare Technologies Ltd pays a Quarterly dividend of ₹2.333 which represents an annual dividend yield of 0.68%. See more information on Thyrocare Technologies Ltd dividends here

What is Thyrocare Technologies Ltd’s EPS estimate?

Thyrocare Technologies Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Thyrocare Technologies Ltd have?

Thyrocare Technologies Ltd has 159,161,700 shares outstanding.

What happened to Thyrocare Technologies Ltd’s price movement after its last earnings report?

Thyrocare Technologies Ltd reported an EPS of ₹4.3 in its last earnings report, missing expectations of ₹4.5. Following the earnings report the stock price went up 1.313%.

Which hedge fund is a major shareholder of Thyrocare Technologies Ltd?

Currently, no hedge funds are holding shares in IN:THYROCARE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Thyrocare Technologies Ltd

Thyrocare Technologies Limited provides diagnostic testing services to patients, laboratories, and hospitals in India. It operates in three segments: Diagnostic Testing Services, Imaging Services, and Others. The company conducts various medical diagnostic tests and profiles of tests that focuses on early detection and management of disorders and diseases, including thyroid, growth, metabolism, auto-immunity, diabetes, anaemia, cardiovascular, infertility, COVID, and various infectious diseases. Its profiles of tests include 34 profiles of tests administered under its Aarogyam brand, which offers patients a suite of wellness and preventive health care tests. The company also sells glucometer and glucostrips under the brand name Sugarscan; consumables; and radiopharmaceutical. Thyrocare Technologies Limited was founded in 1996 and is based in Navi Mumbai, India. Thyrocare Technologies Limited is a subsidiary of Docon Technologies Private Limited.